Savara, Inc. (NASDAQ: SVRA) Securities Fraud Class Action

LEAD PLAINTIFF DEADLINE IS NOVEMBER 7, 2025.

If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at [email protected].

Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Savara, Inc. (“Savara”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period”).

Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its lead product candidate for the treatment of autoimmune pulmonary alveolar proteinosis, MOLBREEVI, is in a Phase 3 IMPALA-2 clinical trial. The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects.  Specifically, Defendants misrepresented and/or failed to disclose that: (1)   MOLBREEVI’s Biologics License Application (“BLA”) lacked sufficient information regarding MOLBREEVI’s chemistry, manufacturing, and/or controls; (2) accordingly, the FDA was unlikely to approve the BLA in its current form; (3) based on the foregoing, it was unlikely that Savara would complete its submission of the BLA within the timeframe it had represented to investors, and would increase the likelihood that Savara would need to raise additional capital; and (4) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
What is a Lead Plaintiff?

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case.  Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.